Stockreport

Intellia: Exciting Promise Of First In Vivo Gene Therapy Makes Bull Case [Seeking Alpha]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF Investing Group Leader Follow Play 16min Summary Intellia Therapeutics is pioneering in vivo CRISPR gene editing, aiming for groundbreaking therapies, with NT [Read more]